GPR119
MOLECULAR TARGETG protein-coupled receptor 119
GPR119 (G protein-coupled receptor 119) is targeted by 7 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GPR119
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | oleoylethanolamide | 3.53 | 33 |
| 2 | Ouabain | 1.10 | 2 |
| 3 | palmidrol [Supplementary Concept] | 0.69 | 1 |
| 4 | Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. | 0.69 | 1 |
| 5 | Dihydroergotamine | 0.69 | 1 |
| 6 | Masoprocol | 0.69 | 1 |
| 7 | Perphenazine | 0.69 | 1 |
About GPR119 as a Drug Target
GPR119 (G protein-coupled receptor 119) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 7 compounds with documented GPR119 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GPR119 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.